Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
May, 27 2026
Sep, 29 2025
Jan, 18 2026
Sep, 28 2025
Jun, 17 2026